Evidence map›Paper›PMID 30211194›Full record

ArticleAnnals of translational medicine2018

Two novel mutations in

Cun Xue, Jinchi Cai, Haiquan Kang, Ying Chen, Kaixuan Wang, Huimin Qian, Changjun Bao, Na Li, Zhen Guo, Zheng Zhang and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Infection and drug resistance · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Cun XueMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Jinchi CaiSchool of Medical Imaging, Xuzhou Medical University, Xuzhou 221004, China.
Haiquan KangDepartment of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
Ying ChenMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Kaixuan WangMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Huimin QianJiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Changjun BaoJiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Na LiMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Zhen GuoMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Zheng ZhangMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Jing WangSchool of Foreign Languages, Shaanxi Normal University, Xi'an 710062, China.
Ping MaMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Bing GuMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Xuzhou Medical College · CNJiangsu Provincial Center for Disease Control and Prevention · CNShaanxi Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study was conducted to assess the resistance capacity of quinolone against

methodsThe number of 81

results2a was the commonest serotype, accounting for 40.7% (33/81) of the 81

conclusionsThis is the first time that a study researches the occurrence of mutations in

Indexed as

JiangsuparEplasmid-mediated quinolone resistance (PMQR)resistanceS. flexneri

Identifiers

PMID30211194
PMCPMC6123205
OpenAlexW2883162749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.